The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 9/25/2026 featuring funding details for Precision Neuroscience and much more. This page will be updated throughout the day to reflect any new fundings.
Precision Neuroscience – $250M
HealthTech
Precision Neuroscience, a medical device company that builds a brain-computer interface restoring communication and movement for people with paralysis and neurological disease, has raised $250M in Series D funding. The round was led by Pershing Square Inc., the Ackman Oxman Institute, and an undisclosed leading life sciences investment fund, with participation from the Duquesne Family Office, B Capital, ARK Investment Management, Invus, Mubadala Capital, Mirae Asset Capital, Korea Investment Partners, Hitachi Ventures, JSL Health Capital, and others. Founded by Benjamin Rapoport, Michael Mager, Demetrios Papageorgiou, and Mark Hettick in 2021, Precision Neuroscience has raised $405M in total equity funding to date.
